Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 5c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q1 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Qualcomm plans new chip architecture for phones - Semafor
• Sinda opens at $10.80, IPO priced at $12
• Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg